Paliperidone Use in Child Psychiatry: Evidence or Diffidence?

Conclusion: Paliperidone has some dynamic and kinetic superiority to the parent drug risperidone. Nonetheless, larger rigorous studies would define the real place of the atypical antipsychotic paliperidone in child and adolescent psychiatry. Until then, risperidone with its long track record in CAP population would remain a first option though.Pharmacology 2019;104:67 –70
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research